Literature DB >> 10906228

Initial interactions of subgenus D adenoviruses with A549 cellular receptors: sialic acid versus alpha(v) integrins.

N Arnberg1, A H Kidd, K Edlund, F Olfat, G Wadell.   

Abstract

Selected members of the adenovirus family have been shown to interact with the coxsackie adenovirus receptor, alpha(v) integrins, and sialic acid on target cells. Initial interactions of subgenus D adenoviruses with target cells have until now been poorly characterized. Here, we demonstrate that adenovirus type 8 (Ad8), Ad19a, and Ad37 use sialic acid as a functional cellular receptor, whereas the Ad9 and Ad19 prototypes do not.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10906228      PMCID： PMC112295          DOI： 10.1128/jvi.74.16.7691-7693.2000

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  19 in total

1.  Adenovirus eye infections in Aberdeen.

Authors:  F M BENNETT; W HAMILTON; B B LAW; A MACDONALD
Journal:  Lancet       Date:  1957-10-05       Impact factor: 79.321

2.  Human adenovirus-host cell interactions: comparative study with members of subgroups B and C.

Authors:  C Defer; M T Belin; M L Caillet-Boudin; P Boulanger
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

3.  Comparative analysis of adenovirus fiber-cell interaction: adenovirus type 2 (Ad2) and Ad9 utilize the same cellular fiber receptor but use different binding strategies for attachment.

Authors:  P W Roelvink; I Kovesdi; T J Wickham
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

4.  Multiple adenovirus serotypes use alpha v integrins for infection.

Authors:  P Mathias; T Wickham; M Moore; G Nemerow
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

Review 5.  Genetic variability of adenoviruses.

Authors:  G Wadell; M L Hammarskjöld; G Winberg; T M Varsanyi; G Sundell
Journal:  Ann N Y Acad Sci       Date:  1980       Impact factor: 5.691

6.  The changing etiology of epidemic keratoconjunctivitis: antigenic and restriction enzyme analyses of adenovirus types 19 and 37 isolated over a 10-year period.

Authors:  M C Kemp; J C Hierholzer; C P Cabradilla; J F Obijeski
Journal:  J Infect Dis       Date:  1983-07       Impact factor: 5.226

7.  Biochemical studies on adenovirus multiplication. XII. Plaquing efficiencies of purified human adenoviruses.

Authors:  M Green; M Piña; R C Kimes
Journal:  Virology       Date:  1967-03       Impact factor: 3.616

8.  Adenoviruses from human immunodeficiency virus-infected individuals, including two strains that represent new candidate serotypes Ad50 and Ad51 of species B1 and D, respectively.

Authors:  J C De Jong; A G Wermenbol; M W Verweij-Uijterwaal; K W Slaterus; P Wertheim-Van Dillen; G J Van Doornum; S H Khoo; J C Hierholzer
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

9.  Fiber genes of adenoviruses with tropism for the eye and the genital tract.

Authors:  N Arnberg; Y f Mei; G Wadell
Journal:  Virology       Date:  1997-01-06       Impact factor: 3.616

10.  Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes.

Authors:  J Gall; A Kass-Eisler; L Leinwand; E Falck-Pedersen
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103
View more
  53 in total

1.  Exploiting the natural diversity in adenovirus tropism for therapy and prevention of disease.

Authors:  M J E Havenga; A A C Lemckert; O J A E Ophorst; M van Meijer; W T V Germeraad; J Grimbergen; M A van Den Doel; R Vogels; J van Deutekom; A A M Janson; J D de Bruijn; F Uytdehaag; P H A Quax; T Logtenberg; M Mehtali; A Bout
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

2.  There are two different species B adenovirus receptors: sBAR, common to species B1 and B2 adenoviruses, and sB2AR, exclusively used by species B2 adenoviruses.

Authors:  Anna Segerman; Niklas Arnberg; Anders Erikson; Kristina Lindman; Göran Wadell
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

3.  Adenovirus type 11 uses CD46 as a cellular receptor.

Authors:  Anna Segerman; John P Atkinson; Marko Marttila; Veronica Dennerquist; Göran Wadell; Niklas Arnberg
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

4.  Crystal structure of species D adenovirus fiber knobs and their sialic acid binding sites.

Authors:  Wim P Burmeister; Delphine Guilligay; Stephen Cusack; Göran Wadell; Niklas Arnberg
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

5.  Use of cell culture-PCR assay based on combination of A549 and BGMK cell lines and molecular identification as a tool to monitor infectious adenoviruses and enteroviruses in river water.

Authors:  Cheonghoon Lee; Seung-Hoon Lee; Euiri Han; Sang-Jong Kim
Journal:  Appl Environ Microbiol       Date:  2004-11       Impact factor: 4.792

6.  CD46 is a cellular receptor for all species B adenoviruses except types 3 and 7.

Authors:  Marko Marttila; David Persson; Dan Gustafsson; M Kathryn Liszewski; John P Atkinson; Göran Wadell; Niklas Arnberg
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

Review 7.  Adenovirus receptors.

Authors:  Yuanming Zhang; Jeffrey M Bergelson
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

8.  The Arg279Gln [corrected] substitution in the adenovirus type 11p (Ad11p) fiber knob abolishes EDTA-resistant binding to A549 and CHO-CD46 cells, converting the phenotype to that of Ad7p.

Authors:  Dan J Gustafsson; Anna Segerman; Kristina Lindman; Ya-Fang Mei; Göran Wadell
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

9.  Coagulation factors IX and X enhance binding and infection of adenovirus types 5 and 31 in human epithelial cells.

Authors:  Mari I Jonsson; Annasara E Lenman; Lars Frängsmyr; Cecilia Nyberg; Mohamed Abdullahi; Niklas Arnberg
Journal:  J Virol       Date:  2009-01-21       Impact factor: 5.103

10.  Adenovirus type 37 uses sialic acid as a cellular receptor on Chang C cells.

Authors:  Niklas Arnberg; Patricia Pring-Akerblom; Göran Wadell
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.